Comments
Loading...
Abbott Laboratories Stock Guidance | NYSE:ABT | Benzinga
Abbott Laboratories issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 01/22/2025 | ABT | Abbott Laboratories | FY | 2025 | $5.05 | $5.25 | $5.16 | — | — | — | Get Alert |
| 01/22/2025 | ABT | Abbott Laboratories | Q1 | 2025 | $1.05 | $1.09 | $1.12 | — | — | — | Get Alert |
| 10/16/2024 | ABT | Abbott Laboratories | Q4 | 2024 | $1.31 | $1.37 | $1.34 | — | — | — | Get Alert |
| 10/16/2024 | ABT | Abbott Laboratories | FY | 2024 | $4.64 | $4.70 | $4.66 | — | — | — | Get Alert |
| 07/18/2024 | ABT | Abbott Laboratories | FY | 2024 | $4.61 | $4.71 | $4.63 | — | — | — | Get Alert |
| 07/18/2024 | ABT | Abbott Laboratories | Q3 | 2024 | $1.18 | $1.22 | $1.20 | — | — | — | Get Alert |
| 04/17/2024 | ABT | Abbott Laboratories | Q2 | 2024 | $1.08 | $1.12 | $1.12 | — | — | — | Get Alert |
| 04/17/2024 | ABT | Abbott Laboratories | FY | 2024 | $4.55 | $4.70 | $4.59 | — | — | — | Get Alert |
| 01/24/2024 | ABT | Abbott Laboratories | FY | 2024 | $4.50 | $4.70 | $4.64 | — | — | — | Get Alert |
| 10/18/2023 | ABT | Abbott Laboratories | Q4 | 2023 | $1.17 | $1.21 | $1.19 | — | — | — | Get Alert |
| 10/18/2023 | ABT | Abbott Laboratories | FY | 2023 | $4.42 | $4.46 | $4.18 | — | — | — | Get Alert |
| 07/20/2023 | ABT | Abbott Laboratories | FY | 2023 | $4.30 | $4.50 | $4.40 | — | — | — | Get Alert |
| 04/19/2023 | ABT | Abbott Laboratories | FY | 2023 | $4.30 | $4.50 | $4.39 | — | — | — | Get Alert |
| 01/25/2023 | ABT | Abbott Laboratories | FY | 2023 | $4.30 | $4.50 | $4.40 | — | — | — | Get Alert |
| 10/19/2022 | ABT | Abbott Laboratories | Q4 | 2022 | $0.86 | $0.92 | $0.96 | — | — | — | Get Alert |
| 10/19/2022 | ABT | Abbott Laboratories | FY | 2022 | $5.17 | $5.23 | $5.05 | — | — | — | Get Alert |
| 07/20/2022 | ABT | Abbott Laboratories | FY | 2022 | $4.90 | — | $4.88 | — | — | — | Get Alert |
| 04/20/2022 | ABT | Abbott Laboratories | FY | 2022 | $4.70 | — | $4.83 | — | — | — | Get Alert |
| 02/18/2022 | ABT | Abbott Laboratories | FY | 2022 | $4.70 | — | $4.85 | — | — | — | Get Alert |
| 01/26/2022 | ABT | Abbott Laboratories | FY | 2022 | $4.70 | — | $4.78 | — | — | — | Get Alert |
| 01/26/2022 | ABT | Abbott Laboratories | Q1 | 2022 | $1.50 | — | $1.13 | — | — | — | Get Alert |
| 10/20/2021 | ABT | Abbott Laboratories | FY | 2021 | $5.00 | $5.10 | $4.45 | — | — | — | Get Alert |
| 07/22/2021 | ABT | Abbott Laboratories | Q3 | 2021 | $0.90 | — | $0.98 | — | — | — | Get Alert |
| 07/22/2021 | ABT | Abbott Laboratories | FY | 2021 | $4.30 | $4.50 | $4.36 | — | — | — | Get Alert |
| 06/01/2021 | ABT | Abbott Laboratories | FY | 2021 | $4.30 | $4.50 | $5.04 | — | — | — | Get Alert |
| 06/01/2021 | ABT | Abbott Laboratories | Q2 | 2021 | $1.00 | — | $1.23 | — | — | — | Get Alert |
| 04/20/2021 | ABT | Abbott Laboratories | FY | 2021 | $5.00 | — | $5.04 | — | — | — | Get Alert |
| 01/27/2021 | ABT | Abbott Laboratories | FY | 2021 | $5.00 | — | $4.37 | — | — | — | Get Alert |
| 10/21/2020 | ABT | Abbott Laboratories | FY | 2020 | $3.55 | — | $3.32 | — | — | — | Get Alert |
| 07/16/2020 | ABT | Abbott Laboratories | FY | 2020 | $3.25 | — | $2.84 | — | — | — | Get Alert |
FAQ
What is the most recent guidance for Abbott Laboratories (ABT)?
The most recent guidance for Abbott Laboratories (ABT) was reported on January 22, 2025 for the full year 2025. The company provided earnings per share guidance in the range of $5.05 to $5.25, compared to the estimated EPS of $5.16. Additionally, Abbott Laboratories forecasted revenue between $0.00B and $0.00B for the quarter.
Browse guidance and forecast on all stocks.